DAROL
Active not recruiting
805 enrolled
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Recruiting
500 enrolled
OBSAPA
Recruiting
270 enrolled
Double-DARE
Recruiting
1,400 enrolled
OPTYX
Active not recruiting
999 enrolled
ROAD
Active not recruiting
1,600 enrolled
DP-04
Recruiting
100 enrolled
PSMAreal
Recruiting
170 enrolled
PULSE
Not yet recruiting
753 enrolled
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Completed
1,247 enrolled
PERSIST
Enrolling by invitation
178 enrolled
PROSTest_STRAT
Not yet recruiting
1,500 enrolled
VAPOR-LTR
Not yet recruiting
2,500 enrolled
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Completed
6,448 enrolled
Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Recruiting
300 enrolled
CONCORD
Recruiting
400 enrolled
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Active not recruiting
60 enrolled
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Completed
1,083 enrolled 29 charts
PRISME
Completed
831 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Completed
3,017 enrolled 5 charts
PRIME
Recruiting
400 enrolled
BARVANA LONG
Completed
70 enrolled
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Completed
979 enrolled
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Completed
507 enrolled 13 charts
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Completed
1,300 enrolled
PETRiS
Recruiting
850 enrolled
A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.
Active not recruiting
1 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completed
1,018 enrolled
CLP-10441
Active not recruiting
80 enrolled
BP-008
Completed
20 enrolled
CLP-10095
Completed
175 enrolled
Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity
Withdrawn
PREDICT
Not yet recruiting
66 enrolled
OLAP
Completed
661 enrolled
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
Completed
13,779 enrolled
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
Active not recruiting
500 enrolled
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Terminated
120 enrolled
LOCUS
Not yet recruiting
64 enrolled
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Completed
2,313 enrolled 5 charts
APCaRI-05
Active not recruiting
2,800 enrolled
An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
Completed
14 enrolled 11 charts
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
Completed
374 enrolled
Evaluation of Prostate Cancer Margins
Completed
100 enrolled
ES-HIFU
Terminated
14 enrolled
PROCeed-BR
Withdrawn